StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) income statement

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.17−0.17 (-1.27%)

Close on Nov 20, 2026Market cap $2.95BP/E 18.8Yield –

See a number that looks wrong?